Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief ...
Travere Therapeutics, Inc. today reported its third quarter 2025 financial results and provided a corporate update. "We delivered outstanding commercial performance in the third quarter, reflecting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback